Literature DB >> 18344743

Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type.

Andrea H Weinberger, Tony P George, Kenneth A Perkins, K N Roy Chengappa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18344743      PMCID： PMC3675443          DOI： 10.1097/JCP.0b013e31816740cf

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  10 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Medication screening for smoking cessation: a proposal for new methodologies.

Authors:  Kenneth A Perkins; Maxine Stitzer; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

3.  Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.

Authors:  Mehmet Sofuoglu; James Poling; Maria Mouratidis; Thomas Kosten
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

4.  Topiramate for smoking cessation.

Authors:  Yasser Khazaal; Jacques Cornuz; Romain Bilancioni; Daniele Fabio Zullino
Journal:  Psychiatry Clin Neurosci       Date:  2006-06       Impact factor: 5.188

5.  Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.

Authors:  Bankole A Johnson; Nassima Ait-Daoud; Fatema Z Akhtar; Martin A Javors
Journal:  Arch Intern Med       Date:  2005-07-25

Review 6.  Co-morbidity of smoking in patients with psychiatric and substance use disorders.

Authors:  David Kalman; Sandra Baker Morissette; Tony P George
Journal:  Am J Addict       Date:  2005 Mar-Apr

7.  A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors.

Authors:  Jose de Leon; Francisco J Diaz
Journal:  Schizophr Res       Date:  2005-07-15       Impact factor: 4.939

8.  Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

Authors:  Bankole A Johnson; Nassima Ait-Daoud; Charles L Bowden; Carlo C DiClemente; John D Roache; Kevin Lawson; Martin A Javors; Jennie Z Ma
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

9.  A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.

Authors:  Kn Roy Chengappa; David J Kupfer; Haranath Parepally; Vineeth John; Ranita Basu; Joan Buttenfield; Patricia Schlicht; Patricia Houck; Jaspreet S Brar; Samuel Gershon
Journal:  Bipolar Disord       Date:  2007-09       Impact factor: 6.744

10.  Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.

Authors:  Malcolm S Reid; Joseph Palamar; Sumithra Raghavan; Frank Flammino
Journal:  Psychopharmacology (Berl)       Date:  2007-03-08       Impact factor: 4.415
  10 in total
  6 in total

Review 1.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

2.  Effects of Topiramate on Smoking in Patients with Schizoaffective Disorder, Bipolar Type: Response to Khazaal and Zullino.

Authors:  Andrea H Weinberger; Tony P George; Kenneth A Perkins; K N Roy Chengappa
Journal:  J Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.153

3.  Major depressive disorder and smoking relapse among adults in the United States: a 10-year, prospective investigation.

Authors:  Michael J Zvolensky; Jafar Bakhshaie; Christine Sheffer; Adriana Perez; Renee D Goodwin
Journal:  Psychiatry Res       Date:  2014-12-09       Impact factor: 3.222

Review 4.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

5.  Topiramate for smoking cessation: Systematic review and meta-analysis.

Authors:  Nesma Lotfy; Hozaifa Elsawah; Mona Hassan
Journal:  Tob Prev Cessat       Date:  2020-02-24

6.  Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials.

Authors:  Robert Pearsall; Daniel J Smith; John R Geddes
Journal:  BMJ Open       Date:  2019-11-28       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.